第一单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.;Harvard Medical School, Boston, MA, United States.
作者：
Shanye,Yin [1]
;
Susan,Klaeger [2]
;
Vipheaviny A,Chea [3]
;
Isabel P,Carulli [3]
;
Suzanna,Rachimi [2]
;
Katharine E,Black [4]
;
Michael,Filbin [5]
;
Lida P,Hariri [6]
;
Rachel S,Knipe [4]
;
Robert F,Padera [7]
;
Jonathan D,Stevens [8]
;
William J,Lane [7]
;
Steven A,Carr [2]
;
Catherine J,Wu [9]
;
Edy Yong,Kim [10]
;
Derin B,Keskin [11]
作者单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.;Harvard Medical School, Boston, MA, United States.
[1]
Broad Institute of MIT and Harvard, Cambridge, MA, United States.
[2]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.;Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, United States.
[3]
Harvard Medical School, Boston, MA, United States.;Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, United States.
[4]
Harvard Medical School, Boston, MA, United States.;Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, United States.
[5]
Harvard Medical School, Boston, MA, United States.;Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, United States.;Department of Pathology, Massachusetts General Hospital, Boston, MA, United States.
[6]
Harvard Medical School, Boston, MA, United States.;Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.
[7]
Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.
[8]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.;Harvard Medical School, Boston, MA, United States.;Broad Institute of MIT and Harvard, Cambridge, MA, United States.;Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
[9]
Harvard Medical School, Boston, MA, United States.;Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States.
[10]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.;Harvard Medical School, Boston, MA, United States.;Broad Institute of MIT and Harvard, Cambridge, MA, United States.;Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, United States.;Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.;Department of Computer Science, Metropolitan College, Boston University, Boston, MA, United States.
[11]
DOI
10.3389/fimmu.2023.1269335
PMID
37942334
发布时间
2024-11-22
换一批
换一批
